BIO-key International (NASDAQ:BKYI) Stock Dropped to “Sell” by Wall Street Zen

Wall Street Zen cut shares of BIO-key International (NASDAQ:BKYI) from a hold rating to a sell rating in a research report sent to investors on Saturday morning,Wall Street Zen reports.

A number of other research firms also recently commented on BKYI. Zacks Research raised shares of BIO-key International to a “hold” rating in a research report on Thursday, August 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of BIO-key International in a research report on Thursday, October 15th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Reduce”.

BIO-key International Stock Down 17.8%

BKYI traded down $0.46 on Friday, reaching $2.12. The company’s stock had a trading volume of 216,234 shares, compared to its average volume of 4,350,114. The company has a market capitalization of $4.31 million, a price-to-earnings ratio of -0.52 and a beta of 0.52. BIO-key International has a fifty-two week low of $1.55 and a fifty-two week high of $10.70. The stock has a 50 day moving average of $2.46 and a two-hundred day moving average of $4.40.

BIO-key International (NASDAQ:BKYI) last released its quarterly earnings data on Friday, November 13th. The technology company reported ($4.01) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.35) by ($3.66). The company had revenue of $1.48 million for the quarter, compared to analyst estimates of $2.40 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. As a group, analysts anticipate that BIO-key International will post -1.62 earnings per share for the current fiscal year.

About BIO-key International

BIO-key International, Inc. (NASDAQ: BKYI) develops biometric authentication and identity and access management solutions. The company helps organizations secure access to applications, networks, devices and data through fingerprint recognition and other authentication methods designed to reduce reliance on passwords. Its product portfolio includes PortalGuard, an identity and access management platform that supports single sign-on, multifactor authentication, self-service password management and access control.